Please Wait
Applying Filters...
menu
    • menu

    List of Drug Master Files (KDMF) for MolPort-001-685-316 Active Pharmaceutical Ingredient (API) submitted to the Review Authority in Korea.

    Client Email Product
    US, Europe turn to advanced manufacturing, stockpiling to strengthen drug supply chains

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

    Stock Recap
    #PipelineProspector

    Menu

    MolPort-001-685-316

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 160Xls download

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    28/09/2024 Hubei Gedian Humanwell Pharmaceutical
    China
    		 Samoh Pharmaceutical Co., Ltd. 20231106-209-J-1317 Oxcarbazepine 2023-11-06 Hubei Gedian Humanwell Pharmaceutical Co., Ltd. China No. 199, Jianshe Avenue, Gedian Economic Development District, E-zhou City, Hubei Province
    28/09/2024 F.I.S. Fabbrica Italiana Sintetici
    Italy
    		 Samoh Pharmaceutical Co., Ltd. 20210819-209-J-1092 Oxcarbazepine 2021-08-19 FIS Fabbrica Italiana Sintetici SpA Italy Viale Milano, 26-36075 MONTECCHIO MAGGIORE (VI), Italy